Nedaplatin in Treatment for Nasopharyngeal Carcinoma

NCT04834206 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Docetaxel, nedaplatin, fluorouracil
RADIATION: IMRT
DRUG: Nedaplatin

Sponsor

Affiliated Cancer Hospital & Institute of Guangzhou Medical University